A PIK3R2 Mutation in Familial Temporal Lobe Epilepsy as a Possible Pathogenic Variant
- PMID: 34040629
- PMCID: PMC8141861
- DOI: 10.3389/fgene.2021.596709
A PIK3R2 Mutation in Familial Temporal Lobe Epilepsy as a Possible Pathogenic Variant
Abstract
Temporal lobe epilepsy (TLE), the most common form of medically refractory focal epilepsy in adults, often requires surgery to alleviate seizures. By using next-generation sequencing, we identified a PIK3R2 mutation (NM_005027.4: c.265C > T; NP_005018.2: p.Arg89Cys) in a family with mesial temporal lobe epilepsy. PIK3R2 encodes p85β, the regulatory subunit of Class IA phosphoinositide 3-kinase (PI3K) and the mutation we identified in PIK3R2 seems to function unexpectedly as a possible pathogenic variant. The mutation is predicted to be potentially pathogenic by multiple bioinformatics tools. Through a functional assay, we verified that the mutation enhances the function of PI3K in induced pluripotent stem cells (iPSCs) derived from peripheral blood mononuclear cells (PBMCs) of the proband. Finally, pathological testing of the resected temporal lobe cortex showed that the expression of PIK3R2 was significantly higher in patients with refractory temporal lobe epilepsy than in those of non-epileptic diseases as a control group. It can be inferred that PIK3R2 might play an important role in the development of TLE.
Keywords: PIK3R2; familial temporal lobe epilepsy; genetic epilepsy; iPSCs; temporal lobe epilepsy.
Copyright © 2021 Wang, Peng, Bai, Yu, He, Fan, Hao and Guan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study.Lancet Neurol. 2015 Dec;14(12):1182-95. doi: 10.1016/S1474-4422(15)00278-1. Epub 2015 Oct 29. Lancet Neurol. 2015. PMID: 26520804 Free PMC article.
-
Age at onset in patients with medically refractory temporal lobe epilepsy and mesial temporal sclerosis: impact on clinical manifestations and postsurgical outcome.Seizure. 2015 Aug;30:42-5. doi: 10.1016/j.seizure.2015.05.015. Epub 2015 May 29. Seizure. 2015. PMID: 26216683
-
Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.J Neurosurg. 2018 Jun;128(6):1668-1673. doi: 10.3171/2017.2.JNS161295. Epub 2017 Jul 28. J Neurosurg. 2018. PMID: 28753112
-
MicroRNAs as potential biomarkers in temporal lobe epilepsy and mesial temporal lobe epilepsy.Neural Regen Res. 2023 Apr;18(4):716-726. doi: 10.4103/1673-5374.354510. Neural Regen Res. 2023. PMID: 36204827 Free PMC article. Review.
-
Molecular typing of familial temporal lobe epilepsy.World J Psychiatry. 2022 Jan 19;12(1):98-107. doi: 10.5498/wjp.v12.i1.98. eCollection 2022 Jan 19. World J Psychiatry. 2022. PMID: 35111581 Free PMC article. Review.
Cited by
-
Transcriptomic analysis reveals distinct adaptive molecular mechanism in the hippocampal CA3 from rats susceptible or not-susceptible to hyperthermia-induced seizures.Sci Rep. 2023 Jun 24;13(1):10265. doi: 10.1038/s41598-023-37535-w. Sci Rep. 2023. PMID: 37355705 Free PMC article.
-
PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis.Clin Transl Oncol. 2023 May;25(5):1402-1412. doi: 10.1007/s12094-022-03036-x. Epub 2022 Dec 17. Clin Transl Oncol. 2023. PMID: 36528701
-
Imaging Genetics in Epilepsy: Current Knowledge and New Perspectives.Front Mol Neurosci. 2022 May 30;15:891621. doi: 10.3389/fnmol.2022.891621. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35706428 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
